307 related articles for article (PubMed ID: 28644958)
1. Translating cancer epigenomics into the clinic: focus on lung cancer.
Mari-Alexandre J; Diaz-Lagares A; Villalba M; Juan O; Crujeiras AB; Calvo A; Sandoval J
Transl Res; 2017 Nov; 189():76-92. PubMed ID: 28644958
[TBL] [Abstract][Full Text] [Related]
2. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
3. Discovery and development of DNA methylation-based biomarkers for lung cancer.
Walter K; Holcomb T; Januario T; Yauch RL; Du P; Bourgon R; Seshagiri S; Amler LC; Hampton GM; S Shames D
Epigenomics; 2014 Feb; 6(1):59-72. PubMed ID: 24579947
[TBL] [Abstract][Full Text] [Related]
4. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
5. [Lung cancer and epigenetic modifications].
Darılmaz Yüce G; Ortaç Ersoy E
Tuberk Toraks; 2016 Jun; 64(2):163-70. PubMed ID: 27481083
[TBL] [Abstract][Full Text] [Related]
6. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
Jankowska AM; Millward CL; Caldwell CW
Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in lung cancer diagnosis and therapy.
Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function.
Deutschmeyer V; Breuer J; Walesch SK; Sokol AM; Graumann J; Bartkuhn M; Boettger T; Rossbach O; Richter AM
Clin Epigenetics; 2019 Dec; 11(1):182. PubMed ID: 31801617
[TBL] [Abstract][Full Text] [Related]
9. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
[TBL] [Abstract][Full Text] [Related]
10. Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis.
Kikutake C; Yahara K
PLoS One; 2016; 11(4):e0152918. PubMed ID: 27042856
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
[TBL] [Abstract][Full Text] [Related]
12. A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.
Sheervalilou R; Shirvaliloo S; Fekri Aval S; Khamaneh AM; Sharifi A; Ansarin K; Zarghami N
Tumour Biol; 2017 May; 39(5):1010428317695032. PubMed ID: 28468581
[TBL] [Abstract][Full Text] [Related]
13. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer epigenetics: From knowledge to applications.
Duruisseaux M; Esteller M
Semin Cancer Biol; 2018 Aug; 51():116-128. PubMed ID: 28919484
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.
Di Paolo A; Del Re M; Petrini I; Altavilla G; Danesi R
Epigenomics; 2016 Aug; 8(8):1151-67. PubMed ID: 27479016
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer epigenetics and genetics.
Risch A; Plass C
Int J Cancer; 2008 Jul; 123(1):1-7. PubMed ID: 18425819
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Biomarkers for Risk Assessment of Particulate Matter Associated Lung Cancer.
Bhargava A; Bunkar N; Aglawe A; Pandey KC; Tiwari R; Chaudhury K; Goryacheva IY; Mishra PK
Curr Drug Targets; 2018; 19(10):1127-1147. PubMed ID: 28891455
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic epigenetic biomarkers in cancer.
Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
[TBL] [Abstract][Full Text] [Related]
20. The significance of epigenetic alterations in lung carcinogenesis.
Brzeziańska E; Dutkowska A; Antczak A
Mol Biol Rep; 2013 Jan; 40(1):309-25. PubMed ID: 23086271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
